Altimmune Inc at Goldman Sachs Healthcare Conference Transcript
Good morning, and thanks for joining us here on the third day of the Goldman Sachs Global Healthcare Conference. Thrilled to be joined on stage today with the management team from Altimmune.
Questions & Answers
And Jerry, I wanted to start with this question because you joined the team in the -- like last year, what drew you to the assets pemvidutide into the company such that you wanted to kind of take on this?
Thanks for the question, Corinne. And more importantly, thanks for having us, glad to be here with you today. So it was pemvidutide the asset that really attracted me to Altimmune. Last year, I have been approached first to join the Board and having spent a long time in liver disease and in MASH specifically previously. For me, I looked at the opportunity, the potential.
This was prior to us getting the Phase 2 data sets.
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
